IPCI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Intellipharmaceutics International Inc

Watchlist Manager

Watchlist

Price: 0.08 CAD

Market Cap: CA$2.8m

	Intellipharmaceutics International Inc TSX:IPCI	CA
A	Ashirwad Capital Ltd BSE:512247	IN
	Hopson Development Holdings Ltd HKEX:754	HK
V	VICI Properties Inc F:1KN	US

Profitability Summary

Intellipharmaceutics International Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-89%

Negative 3Y Average Gross Margin

-89%

Declining Gross Margin

-89% > -89%

Negative Operating Margin

-285%

Negative 3Y Average Operating Margin

-285%

Declining Operating Margin

-285% > -285%

Negative Net Margin

-351%

Negative 3Y Average Net Margin

-351%

Declining Net Margin

-351% > -351%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

13%

Declining Free Cash Flow Margin

13% > 13%

Exceptional ROE

28%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

92%

Declining ROIC

92% > 92%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-89%

Negative 3Y Average Gross Margin

-89%

Declining Gross Margin

-89% > -89%

Negative Operating Margin

-285%

Negative 3Y Average Operating Margin

-285%

Declining Operating Margin

-285% > -285%